Time course of thrombosis and fibrinolysis during total hip surgery

Journal of Orthopaedics and Traumatology

Volumn 7, Issue 4, 2006, Pages 187-191

  Reikerås, Olav ^a   Clementsen, T ^a   Bjornsen S ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Anticoagulation; Arthroplasty; Fibrinolysis; Orthopaedic surgery; Thrombosis

Indexed keywords

ANTIPLASMIN; CEFALOTIN; D DIMER; DALTEPARIN; FIBRIN; PLASMIN; PROTHROMBIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTIVE SURGERY; FEMALE; FIBRINOLYSIS; HIP SURGERY; HUMAN; INTRAOPERATIVE PERIOD; MALE; OPERATION DURATION; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOGENESIS; TIME; TOTAL HIP PROSTHESIS; VEIN THROMBOSIS; WOUND CLOSURE;

EID: 33846102855     PISSN: 15909921     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10195-006-0146-5     Document Type: Article

References (40)

1. Nicolaides AN, Bergqvist D, Hull RD (1997) Prevention of venous thromboembolism: International consensus statement. Int Angiol 16:3-38
2. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, Wheeler HB (1998) Prevention of venous thromboembolism. Chest 114:531S-560S
3. Sharnoff JG, DeBlasio G (1970) Prevention of fatal postoperative thromboembolism by heparin prophylaxis. Lancet 2:1006-1007
4. Gallus AS, Hirsh J, Tuttle RJ, McBride JA, Tuttle RJ, Gent M (1973) Small subcutaneous doses of heparin in prevention of venous thrombosis. N Engl J Med 288:545-551
5. Dahl OE, Aspelin T, Lyberg T (1995) The role of bone traumatization in the initiation of proximal deep vein thrombosis during cemented hip replacement surgery in pigs. Blood Coagul Fibrinolysis 6:709-717
6. Dahl OE, Andreassen G, Aspelin T, Muller C, Mathiesen P, Nyhus S, Abdelnoor M, Solhaug JH, Arnesen H (1997) Prolonged thromboprophylaxis following hip replacement surgery: Results of a double-blind prospective, randomized, placebo-controlled study with dalteparin (Fragmin). Thromb Haemost 77:26-31
7. Hull RD, Brant RF, Pineo GF, Stein PD, Raskob GE, Valentine KA (1999) Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacement. Arch Intern Med 159:137-141
8. Planes A, Vochelle N, Fagola M, Feret J, Bellaud M (1991) Prevention of deep vein thrombosis after total hip replacement: The effect of low-molecular-weight heparin with spinal and general anaesthesia. J Bone Joint Surg Br 73:418-423
9. Planes A (1993) Comparison of anti-thrombotic efficacy and haemorrhagic side effects of Clivarin versus enoxaparin in patients undergoing total hip replacement surgery. Blood Coagul Fibrinolysis 4[Suppl 1]:S33-S38
10. Planes A, Vochelle N, Darmon JY, Fagola M, Bellaud M, Huet Y (1996) Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: Double-blind randomized comparison of enoxaparin versus placebo. Lancet 348:224-228
11. Planes A, Samama M, Lensing A, Buller HR, Barre J, Vochelle N, Beau B (1999) Prevention of deep vein thrombosis after total hip replacement: comparison between two low-molecularweight heparins, tinzaparin and enoxaparin. Thromb Haemost 81:22-25
12. Danish Enoxaparin Study Group (1991) Low-molecular weight heparin (enoxaparin) vs dextran 70: The prevention of postoperative deep vein thrombosis after total hip replacement. Arch Intern Med 151:1621-1624
13. Eriksson BI, Kälebo P, Anthmyr BA, Wadenvik H, Tengborn L, Risberg B (1991) Prevention of deep vein thrombosis and pulmonary embolism after total hip replacement. J Bone Joint Surg Am 73:484-493
14. Eriksson B, Wille-Jorgensen P, Kalebo P, Mouret P, Rosencher N, Bosch P, Baur M, Ekman S, Bach D, Lindbratt S, Close P (1997) A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement. N Engl J Med 337:1329-1335
15. Lassen MR, Borris LC, Christiansen HM, Boll KL, Eiskjaer SP, Nielsen BW, Schott P, Olsen AD, Rodenberg JC, Lucht U (1991) Prevention of thromboembolism in 190 hip arthroplasties. Acta Orthop Scand 62:33-38
16. Leyvraz PF, Bachmann F, Hoek J, Buller HR, Postel M, Samama M, Vandenbroek MD (1991) Prevention of deep vein thrombosis after hip replacement: Randomized comparison between unfractionated heparin and low molecular weight heparin. Br Med J 303:543-548
17. Torholm C, Broeng L, Jorgensen PS, Bjerregaard P, Josephsen L, Jorgensen PK, Hagen K, Knudsen JB (1991) Thromboprophylaxis by low-molecular-weight heparin in elective hip surgery: A placebo controlled study. J Bone Joint Surg Br 73:434-438
18. The German Hip Arthroplasty Trial (GHAT) Group (1992) Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement: A randomized trial. Arch Orthop Trauma Surg 111:110-120
19. Hamulyák K, Lensing AW, van der Meer J, Smid WM, van Ooy A, Hoek JA (1995) Subcutaneous low-molecularweight heparin or oral anticoagulants for the prevention of deep-vein thrombosis in elective hip and knee replacement? Thromb Haemost 74:1428-1431
20. Bergqvist D, Benoni G, Bjorgell O, Fredin H, Hedlundh U, Nicolas S, Nilsson P, Nylander G (1996) Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 335:696-700
21. Samama CM, Clergue F, Barre J, Montefiore A, Ill P, Samii K (1997) Low molecular weight heparin associated with spinal anaesthesia and gradual compression stockings in total hip replacement surgery. Br J Anaesth 78:660-665
22. Turpie AGG, Levine MN, Hirsh J (1986) A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 315:925-929
23. Levine MN, Hirsh J, Gent M, Turpie AG, Leclerc J, Powers PJ, Jay RM, Neemeh J (1991) Prevention of deep vein thrombosis after elective hip surgery: A randomized trial comparing low molecular weight heparin with standard unfractionated heparin. Ann Intern Med 114:545-551
24. Colwell CW Jr, Spiro TE, Trowbridge AA, Morris BA, Kwaan HC, Blaha JD, Comerota AJ, Skoutakis VA (1994) Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement: A clinical trial comparing efficacy and safety. J Bone Joint Surg Am 76:3-14
25. Spiro TE, Johnson CJ, Christie MJ (1994) Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Ann Intern Med 121:81-89
26. Kearon C, Hirsh J (1995) Starting prophylaxis for venous thromboembolism postoperatively. Arch Intern Med 155:366-372
27. Horlocker TT, Heit JA (1997) Low molecular weight heparin: Biochemistry, pharmacology, perioperative prophylaxis regimens and guidelines for regional anesthetic management. Anesth Analg 85:874-885
28. Lumpkin MM (1998) FDA alert: FDA public health advisory. Anesthesiology 88:27A-28A
29. Ekbäck G, Axelsson K, Rytterberg L, Edlund B, Kjellberg J, Weckström J, Carlsson O, Schött U (2000) Tranexamic acid reduces blood loss in total hip replacement surgery. Anesth Analg 91:1124-1130
30. Benoni G, Fredin H, Knebel R, Nilsson P (2001) Blood conservation with tranexamic acid in total hip arthroplasty: A randomized, double blind study in 40 primary operations. Acta Orthop Scand 72:442-448
31. Husted H, Blond L, Sonne-Holm S, Holm G, Jacobsen TW, Gebuhr P (2003) Tranexamic acid reduces blood loss and blood transfusions in primary total hip arthroplasty: A prospective randomized double-blind study in 40 patients. Acta Orthop Scand 74:665-669
32. Johansson T, Petterson LG, Lisander B (2005) Tranexamic acid in total hip arthoplasty saves blood and money. Acta Orthop 76:314-319
33. Conway EM, Bauer KA, Barzegar S, Riosenberg RD (1987) Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses. J Clin Invest 80:1535-1544
34. Sharrock NE, Go G, Harpel PC, Ranawat CS, Sculco TP, Salvati EA (1995) Thrombogenesis during hip arthroplasty. Clin Othop Relat Res 319:16-27
35. Gando S, Tedo I, Kubiota M (1992) Post trauma coagulation and fibrinolysis. Crit Care Med 20:594-600
36. Kluft C, Verheijen JH, Jie AF, Rijken DC, Preston FE, Sue-Ling HM, Jespersen J, Aasen AO (1985) The postoperative fibrinolytic shutdown: A rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scand J Clin Lab Invest 45:605-610
37. Boneu B, Bes G, Pelzer H, Sie P, Boccalon H (1991) D-Dimers, thrombin antithrombin III complexes and prothrombin fragment 1+2: Diagnostic value in clinically suspected deep vein thrombosis. Thromb Haemost 65:28-32
38. Hull RD, Pieno GF, Stein PD, Mah AF, MacIsaac SM, Dahl OE, Ghali WA, Butcher MS, Brant RF, Bergqvist D, Hamulyák K, Francis CW, Marder VJ, Raskob GE (2001) Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty. Arch Intern Med 161:1952-1960
39. Francis CW, Pellegrini VD Jr, Totterman S, Boyd AD Jr, Marder VJ, Liebert KM, Stulberg BN, Ayers DC, Rosenberg A, Kessler C, Johanson NA (1997) Prevention of deep-vein thrombosis after total hip arthroplasty: comparison of warfarin and dalteparin. J Bone Joint Surg Am 79:1365-1372
40. Hull RD, Pineo GF, Francis C, Bergqvist D, Fellenius C, Soderberg K, Holmqvist A, Mant M, Dear R, Baylis B, Mah A, Brant R (2000) Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: A double-blind, randomized comparison. Arch Intern Med 160:2199-2207